According to public statements and social media posts from X, ACIP vice chair Robert Malone (a public ally of HHS secretary Robert F. Kennedy Jr.) publicly accused FDA Commissioner Marty Makary of ...

On February 1, FDA announced a new pilot program designed to promote the construction of domestic manufacturing sites, along ...

Eli Lilly is investing $3.5 billion in a new manufacturing facility in Lehigh Valley, Pennsylvania, to produce injectable ...

In today’s Pharmaceutical Executive Daily, the FDA introduces a PreCheck pilot program aimed at strengthening domestic manufacturing oversight, an ACIP member alleges FDA leadership halted a decision ...

AstraZeneca entered a strategic collaboration with CSPC Pharmaceuticals to expand its weight management and metabolic disease ...

Seamless Therapeutics entered into a strategic global research collaboration and licensing agreement with Eli Lilly and ...

The deal underscores a broader shift in autoimmune drug development toward therapies that aim to reprogram disease-driving ...

PE: After presenting topline results from Phase 3 trials, what's next for Varegacestat? Siegall: We presented topline data.

Roche reported positive Phase II topline data showing that its once-weekly dual glucagon-like peptide-1 and glucose-dependent ...

Teva's Honestly HD campaign, featuring Will Forte, aims to raise awareness about Huntington's disease through personal ...

The real “commercial launch” happens years before launch preparation officially begins. Once Phase III begins, your evidence ...

The US Department of Health and Human Services (HHS) issued new guidance clarifying how pharmaceutical manufacturers can ...